112 related articles for article (PubMed ID: 11133101)
1. Synthesis and structure-activity relationships of 3-cyano-4-(phenoxyanilino)quinolines as MEK (MAPKK) inhibitors.
Zhang N; Wu B; Powell D; Wissner A; Floyd MB; Kovacs ED; Toral-Barza L; Kohler C
Bioorg Med Chem Lett; 2000 Dec; 10(24):2825-8. PubMed ID: 11133101
[TBL] [Abstract][Full Text] [Related]
2. MEK (MAPKK) inhibitors. Part 2: structure-activity relationships of 4-anilino-3-cyano-6,7-dialkoxyquinolines.
Zhang N; Wu B; Eudy N; Wang Y; Ye F; Powell D; Wissner A; Feldberg LR; Kim SC; Mallon R; Kovacs ED; Toral-Barza L; Kohler CA
Bioorg Med Chem Lett; 2001 Jun; 11(11):1407-10. PubMed ID: 11378365
[TBL] [Abstract][Full Text] [Related]
3. The design, synthesis and biological evaluation of 7-alkoxy-4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS.
Cao X; You QD; Li ZY; Liu XR; Xu D; Guo QL; Shang J; Chern JW; Chen ML
Bioorg Med Chem Lett; 2008 Dec; 18(23):6206-9. PubMed ID: 18930653
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 4-anilino-6,7-dialkoxy-3-quinolinecarbonitriles as inhibitors of kinases of the Ras-MAPK signaling cascade.
Berger D; Dutia M; Powell D; Wu B; Wissner A; Boschelli DH; Floyd MB; Zhang N; Torres N; Levin J; Du X; Wojciechowicz D; Discafani C; Kohler C; Kim SC; Feldberg LR; Collins K; Mallon R
Bioorg Med Chem Lett; 2003 Sep; 13(18):3031-4. PubMed ID: 12941327
[TBL] [Abstract][Full Text] [Related]
5. 4-Anilino-3-cyanobenzo[g]quinolines as kinase inhibitors.
Zhang N; Wu B; Wissner A; Powell DW; Rabindran SK; Kohler C; Boschelli F
Bioorg Med Chem Lett; 2002 Feb; 12(3):423-5. PubMed ID: 11814812
[TBL] [Abstract][Full Text] [Related]
6. 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors.
Wissner A; Berger DM; Boschelli DH; Floyd MB; Greenberger LM; Gruber BC; Johnson BD; Mamuya N; Nilakantan R; Reich MF; Shen R; Tsou HR; Upeslacis E; Wang YF; Wu B; Ye F; Zhang N
J Med Chem; 2000 Aug; 43(17):3244-56. PubMed ID: 10966743
[TBL] [Abstract][Full Text] [Related]
7. 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as dual inhibitors of Src and Abl kinases.
Boschelli DH; Wang YD; Johnson S; Wu B; Ye F; Barrios Sosa AC; Golas JM; Boschelli F
J Med Chem; 2004 Mar; 47(7):1599-601. PubMed ID: 15027848
[TBL] [Abstract][Full Text] [Related]
8. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
Berger DM; Dutia M; Birnberg G; Powell D; Boschelli DH; Wang YD; Ravi M; Yaczko D; Golas J; Lucas J; Boschelli F
J Med Chem; 2005 Sep; 48(19):5909-20. PubMed ID: 16161995
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles.
Boschelli DH; Wang YD; Ye F; Wu B; Zhang N; Dutia M; Powell DW; Wissner A; Arndt K; Weber JM; Boschelli F
J Med Chem; 2001 Mar; 44(5):822-33. PubMed ID: 11262092
[TBL] [Abstract][Full Text] [Related]
10. 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.
Zhang N; Wu B; Boschelli DH; Golas JM; Boschelli F
Bioorg Med Chem Lett; 2009 Sep; 19(17):5071-4. PubMed ID: 19632113
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Src kinase activity by 4-anilino-7-thienyl-3-quinolinecarbonitriles.
Boschelli DH; Wang DY; Ye F; Yamashita A; Zhang N; Powell D; Weber J; Boschelli F
Bioorg Med Chem Lett; 2002 Aug; 12(15):2011-4. PubMed ID: 12113830
[TBL] [Abstract][Full Text] [Related]
12. Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity.
Boschelli DH; Ye F; Wang YD; Dutia M; Johnson SL; Wu B; Miller K; Powell DW; Yaczko D; Young M; Tischler M; Arndt K; Discafani C; Etienne C; Gibbons J; Grod J; Lucas J; Weber JM; Boschelli F
J Med Chem; 2001 Nov; 44(23):3965-77. PubMed ID: 11689083
[TBL] [Abstract][Full Text] [Related]
13. Substituted 4-anilino-7-phenyl-3-quinolinecarbonitriles as Src kinase inhibitors.
Berger D; Dutia M; Powell D; Wissner A; DeMorin F; Raifeld Y; Weber J; Boschelli F
Bioorg Med Chem Lett; 2002 Oct; 12(20):2989-92. PubMed ID: 12270190
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Src kinase activity by 7-ethynyl-4-phenylamino-3-quinolinecarbonitriles: identification of SKS-927.
Boschelli DH; Barrios Sosa AC; Golas JM; Boschelli F
Bioorg Med Chem Lett; 2007 Mar; 17(5):1358-61. PubMed ID: 17188862
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and biological evaluation of 3-quinolinecarbonitrile-7-amide derivatives].
Liu B; You QD; Li ZY
Yao Xue Xue Bao; 2009 Aug; 44(8):879-84. PubMed ID: 20055156
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel 6,7-dimethoxy-4-anilinoquinolines as potent c-Met inhibitors.
Zhang QW; Ye ZD; Shen C; Tie HX; Wang L; Shi L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):124-133. PubMed ID: 30422010
[TBL] [Abstract][Full Text] [Related]
17. Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment.
Miller LM; Mayer SC; Berger DM; Boschelli DH; Boschelli F; Di L; Du X; Dutia M; Floyd MB; Johnson M; Kenny CH; Krishnamurthy G; Moy F; Petusky S; Tkach D; Torres N; Wu B; Xu W
Bioorg Med Chem Lett; 2009 Jan; 19(1):62-6. PubMed ID: 19041240
[TBL] [Abstract][Full Text] [Related]
18. Novel dithiocarbamic acid esters derived from 6-aminomethyl-4-anilinoquinazolines and 6-aminomethyl-4-anilino-3-cyanoquinolines as potent EGFR inhibitors.
Zhang X; Li R; Qiao K; Ge Z; Zhang L; Cheng T; Li R
Arch Pharm (Weinheim); 2013 Jan; 346(1):44-52. PubMed ID: 23180607
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel 2,3-dihydro-1,4-dioxino[2,3-g]quinoline derivatives as potential antitumor agents.
Vázquez MT; Romero M; Pujol MD
Bioorg Med Chem; 2004 Mar; 12(5):949-56. PubMed ID: 14980607
[TBL] [Abstract][Full Text] [Related]
20. [The design, synthesis and anticancer activity of 4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS].
Cao X; You QD; Li ZY; Guo QL; Yang Y; Shang J; Yan M; Chen JW; Chen ML
Yao Xue Xue Bao; 2009 Mar; 44(3):288-95. PubMed ID: 19449526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
